SR

Sudesh Rattan

Director Director DIN 03226992
DIN 03226992 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudesh Rattan

Data last updated:

Sudesh Rattan was a Director at Pharmaclinix India Private Limited (2014–2019) and Director at Avy Capital Advisors Private Limited (from 2011). The companies operate in Pharma.

DIN 03226992
Primary Designation Director
Industry Pharma
First Appointment 24 Nov 2011
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmaclinix India Private Limited U74140HR2014PTC052123
Director11 Mar 20142014₹3.5 Lakh (FY 2018)Active
Avy Capital Advisors Private Limited U74140MH2011PTC224349
Director24 Nov 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avy Capital Advisors Private Limited
Pharmaclinix India Private Limited
Premium access

Shareholding and investment profile for Sudesh Rattan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudesh Rattan

Sudesh Rattan was first appointed on 24 Nov 2011 as Director at Avy Capital Advisors Private Limited. The most recent appointment on record is 11 Mar 2014 at Pharmaclinix India Private Limited.

Sudesh Rattan held 2 earlier board appointments: Pharmaclinix India Private Limited (Director, 11 Mar 2014 to 28 Feb 2019); Avy Capital Advisors Private Limited (Director, from 24 Nov 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available